NGSベースのRNAシーケンシング市場調査レポートー2032年までの市場予測

レポートナンバー　0000038512

バイオ・ゲノム・再生医療

NGSベースのRNAシーケンシング市場調査レポートー2032年までの市場予測

Market Research Future

NGS-based RNA-sequencing Market Research Report - Market Forecast till 2032

発刊日 2024/06

言語英語

体裁PDF/128ページ

ライセンス/価格128ページ

0000038512

Single	4,950USD
Multiuser	5,950USD
Enterprise	7,250USD

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

お問い合わせ

サンプル依頼

無料サンプル

サンプルはお問い合わせください。

レポート概要

NGSベースのRNAシーケンシング市場調査レポート情報:製品・サービス別(サンプル調製製品、シーケンシングプラットフォームおよび消耗品、シーケンシングサービスおよびデータ解析、保管および管理)、技術別(合成シーケンシング(SBS)、イオン半導体シーケンシング、1分子リアルタイムシーケンシング(SMRT)、ナノポアシーケンシング)、アプリケーション別(発現プロファイリング解析、small RNAシーケンシング、de novoトランスクリプトームアセンブリ、バリアントコール、トランスクリプトーム)エピジェネティクス)、エンドユーザー別(研究・学術、病院・診療所、製薬・バイオ企業)、地域別(北米、欧州、アジア太平洋、その他の地域)-2032年までの市場予測

NGSベースのRNAシーケンシングの世界市場の概要

NGSベースのRNAシーケンシングの市場規模は、2023年に27億ドルと評価され、2024年の32億ドルから2032年までに124億ドルに成長し、予測期間 (2024〜2032年) の間に21.00%のCAGRを示すと予測されます。技術の進歩と個別化医療に対する需要の高まりが、主要な市場推進要因です。

レポート詳細

3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2.Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation

4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities

5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis

6. GLOBAL NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT AND SERVICE
6.1. Overview
6.2. Sample Preparation Products
6.3. Sequencing Platforms and Consumables
6.4. Sequencing Services
6.5. Data Analysis, Storage and Management

7. GLOBAL NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY
7.1. Overview
7.2. Sequencing by Synthesis (SBS)
7.3. Ion Semiconductor Sequencing
7.4. Single-molecule Real-time Sequencing (SMRT)
7.5. Nanopore Sequencing

8. GLOBAL NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION
8.1. Overview
8.2. Expression Profiling Analysis
8.3. Small RNA Sequencing
8.4. De Novo Transcriptome Assembly
8.5. Variant Calling and Transcriptome Epigenetics

9. GLOBAL NGS-BASED RNA-SEQUENCING MARKET, BY END-USER
9.1. Overview
9.2. Research and Academia
9.3. Hospitals and Clinics
9.4. Pharmaceutical and Biotechnology Companies

10. GLOBAL NGS-BASED RNA-SEQUENCING MARKET, BY REGION
10.1. Overview
10.1. North America
10.1.1. US
10.1.2. Canada
10.2. Europe
10.2.1. Germany
10.2.2. France
10.2.3. UK
10.2.4. Italy
10.2.5. Spain
10.2.6. Rest of Europe
10.3. Asia-Pacific
10.3.1. China
10.3.2. India
10.3.3. Japan
10.3.4. South Korea
10.3.5. Australia
10.3.6. Rest of Asia-Pacific
10.4. Rest of the World
10.4.1. Middle East
10.4.2. Africa
10.4.3. Latin America

11. COMPETITIVE LANDSCAPE
11.1. Overview
11.2. Competitive Analysis
11.3. Market Share Analysis
11.4. Major Growth Strategy in the Global NGS-based RNA-sequencing Market,
11.5. Competitive Benchmarking
11.6. Leading Players in Terms of Number of Developments in the Global NGS-based RNA-sequencing Market,
11.7. Key developments and Growth Strategies
11.7.1. New Product and Service Launch/Service Deployment
11.7.2. Merger & Acquisitions
11.7.3. Joint Ventures
11.8. Major Players Financial Matrix
11.8.1. Sales & Operating Income, 2023
11.8.2. Major Players R&D Expenditure. 2023

12. COMPANY PROFILES
12.1. Illumina
12.1.1. Company Overview
12.1.2. Financial Overview
12.1.3. Product and Services Offered
12.1.4. Key Developments
12.1.5. SWOT Analysis
12.1.6. Key Strategies
12.2. Thermo Fischer Scientific
12.2.1. Company Overview
12.2.2. Financial Overview
12.2.3. Product and Services Offered
12.2.4. Key Developments
12.2.5. SWOT Analysis
12.2.6. Key Strategies
12.3. Oxford Nanopore
12.3.1. Company Overview
12.3.2. Financial Overview
12.3.3. Product and Services Offered
12.3.4. Key Developments
12.3.5. SWOT Analysis
12.3.6. Key Strategies
12.4. Agilent Technologies, Inc.
12.4.1. Company Overview
12.4.2. Financial Overview
12.4.3. Product and Services Offered
12.4.4. Key Developments
12.4.5. SWOT Analysis
12.4.6. Key Strategies
12.5. BGI
12.5.1. Company Overview
12.5.2. Financial Overview
12.5.3. Product and Services Offered
12.5.4. Key Developments
12.5.5. SWOT Analysis
12.5.6. Key Strategies
12.6. PerkinElmer Inc.
12.6.1. Company Overview
12.6.2. Financial Overview
12.6.3. Product and Services Offered
12.6.4. Key Developments
12.6.5. SWOT Analysis
12.6.6. Key Strategies
12.7. QIAGEN
12.7.1. Company Overview
12.7.2. Financial Overview
12.7.3. Product and Services Offered
12.7.4. Key Developments
12.7.5. SWOT Analysis
12.7.6. Key Strategies
12.8. EUROFINS SCIENTIFIC
12.8.1. Company Overview
12.8.2. Financial Overview
12.8.3. Product and Services Offered
12.8.4. Key Developments
12.8.5. SWOT Analysis
12.8.6. Key Strategies
12.9. Hoffmann-La Roche Ltd
12.9.1. Company Overview
12.9.2. Financial Overview
12.9.3. Product and Services Offered
12.9.4. Key Developments
12.9.5. SWOT Analysis
12.9.6. Key Strategies
12.10. Takara Bio Inc.
12.10.1. Company Overview
12.10.2. Financial Overview
12.10.3. Product and Services Offered
12.10.4. Key Developments
12.10.5. SWOT Analysis
12.10.6. Key Strategies
12.11. Tecan Genomics, Inc
12.11.1. Company Overview
12.11.2. Financial Overview
12.11.3. Product and Services Offered
12.11.4. Key Developments
12.11.5. SWOT Analysis
12.11.6. Key Strategies

13. APPENDIX
13.1. References
13.2. Related Reports

LIST OF TABLES
TABLE 1 GLOBAL NGS-BASED RNA-SEQUENCING MARKET, SYNOPSIS, 2019-2032
TABLE 2 GLOBAL NGS-BASED RNA-SEQUENCING MARKET, ESTIMATES & FORECAST, 2019-2032 (USD BILLION)
TABLE 3 GLOBAL NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2019-2032 (USD BILLION)
TABLE 4 GLOBAL NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 5 GLOBAL NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 6 GLOBAL NGS-BASED RNA-SEQUENCING MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 7 NORTH AMERICA: NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2019-2032 (USD BILLION)
TABLE 8 NORTH AMERICA: NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 9 NORTH AMERICA: NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 10 NORTH AMERICA: NGS-BASED RNA-SEQUENCING MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 11 US: NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2019-2032 (USD BILLION)
TABLE 12 US: NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 13 US: NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 14 US: NGS-BASED RNA-SEQUENCING MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 15 CANADA: NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2019-2032 (USD BILLION)
TABLE 16 CANADA: NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 17 CANADA: NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 18 CANADA: NGS-BASED RNA-SEQUENCING MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 1 EUROPE: NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2019-2032 (USD BILLION)
TABLE 2 EUROPE: NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 3 EUROPE: NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 4 EUROPE: NGS-BASED RNA-SEQUENCING MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 5 GERMANY: NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2019-2032 (USD BILLION)
TABLE 6 GERMANY: NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 7 GERMANY: NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 8 GERMANY: NGS-BASED RNA-SEQUENCING MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 9 FRANCE: NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2019-2032 (USD BILLION)
TABLE 10 FRANCE: NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 11 FRANCE: NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 12 FRANCE: NGS-BASED RNA-SEQUENCING MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 13 ITALY: NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2019-2032 (USD BILLION)
TABLE 14 ITALY: NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 15 ITALY: NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 16 ITALY: NGS-BASED RNA-SEQUENCING MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 17 SPAIN: NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2019-2032 (USD BILLION)
TABLE 18 SPAIN: NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 19 SPAIN: NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 20 SPAIN: NGS-BASED RNA-SEQUENCING MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 21 UK: NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2019-2032 (USD BILLION)
TABLE 22 UK: NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 23 UK: NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 24 UK: NGS-BASED RNA-SEQUENCING MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 25 REST OF EUROPE: NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2019-2032 (USD BILLION)
TABLE 26 REST OF EUROPE: NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 27 REST OF EUROPE: NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 28 REST OF EUROPE: NGS-BASED RNA-SEQUENCING MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 29 ASIA-PACIFIC: NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2019-2032 (USD BILLION)
TABLE 30 ASIA-PACIFIC: NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 31 ASIA-PACIFIC: NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 32 ASIA-PACIFIC: NGS-BASED RNA-SEQUENCING MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 33 JAPAN: NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2019-2032 (USD BILLION)
TABLE 34 JAPAN: NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 35 JAPAN: NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 36 JAPAN: NGS-BASED RNA-SEQUENCING MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 37 CHINA: NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2019-2032 (USD BILLION)
TABLE 38 CHINA: NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 39 CHINA: NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 40 CHINA: NGS-BASED RNA-SEQUENCING MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 41 INDIA: NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2019-2032 (USD BILLION)
TABLE 42 INDIA: NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 43 INDIA: NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 44 INDIA: NGS-BASED RNA-SEQUENCING MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 45 AUSTRALIA: NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2019-2032 (USD BILLION)
TABLE 46 AUSTRALIA: NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 47 AUSTRALIA: NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 48 AUSTRALIA: NGS-BASED RNA-SEQUENCING MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 49 SOUTH KOREA: NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2019-2032 (USD BILLION)
TABLE 50 SOUTH KOREA: NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 51 SOUTH KOREA: NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 52 SOUTH KOREA: NGS-BASED RNA-SEQUENCING MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 53 REST OF ASIA-PACIFIC: NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2019-2032 (USD BILLION)
TABLE 54 REST OF ASIA-PACIFIC: NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 55 REST OF ASIA-PACIFIC: NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 56 REST OF ASIA-PACIFIC: NGS-BASED RNA-SEQUENCING MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 57 REST OF THE WORLD: NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2019-2032 (USD BILLION)
TABLE 58 REST OF THE WORLD: NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 59 REST OF THE WORLD: NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 60 REST OF THE WORLD: NGS-BASED RNA-SEQUENCING MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 61 MIDDLE EAST: NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2019-2032 (USD BILLION)
TABLE 62 MIDDLE EAST: NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 63 MIDDLE EAST: NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 64 MIDDLE EAST: NGS-BASED RNA-SEQUENCING MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 65 AFRICA: NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2019-2032 (USD BILLION)
TABLE 66 AFRICA: NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 67 AFRICA: NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 68 AFRICA: NGS-BASED RNA-SEQUENCING MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 69 LATIN AMERICA: NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2019-2032 (USD BILLION)
TABLE 70 LATIN AMERICA: NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 71 LATIN AMERICA: NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 72 LATIN AMERICA: NGS-BASED RNA-SEQUENCING MARKET, BY END-USER, 2019-2032 (USD BILLION)

LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL NGS-BASED RNA-SEQUENCING MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL NGS-BASED RNA-SEQUENCING MARKET
FIGURE 4 GLOBAL NGS-BASED RNA-SEQUENCING MARKET, SHARE (%), BY PRODUCT AND SERVICE, 2023
FIGURE 5 GLOBAL NGS-BASED RNA-SEQUENCING MARKET, SHARE (%), BY TECHNOLOGY, 2023
FIGURE 6 GLOBAL NGS-BASED RNA-SEQUENCING MARKET, SHARE (%), BY APPLICATION, 2023
FIGURE 7 GLOBAL NGS-BASED RNA-SEQUENCING MARKET, SHARE (%), BY END-USER, 2023
FIGURE 8 GLOBAL NGS-BASED RNA-SEQUENCING MARKET, SHARE (%), BY REGION, 2023
FIGURE 9 NORTH AMERICA: NGS-BASED RNA-SEQUENCING MARKET, SHARE (%), BY REGION, 2023
FIGURE 10 EUROPE: NGS-BASED RNA-SEQUENCING MARKET, SHARE (%), BY REGION, 2023
FIGURE 11 ASIA-PACIFIC: NGS-BASED RNA-SEQUENCING MARKET, SHARE (%), BY REGION, 2023
FIGURE 12 REST OF THE WORLD: NGS-BASED RNA-SEQUENCING MARKET, SHARE (%), BY REGION, 2023
FIGURE 13 GLOBAL NGS-BASED RNA-SEQUENCING MARKET: COMPANY SHARE ANALYSIS, 2023 (%)
FIGURE 14 ILLUMINA: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 15 ILLUMINA: SWOT ANALYSIS
FIGURE 16 THERMO FISCHER SCIENTIFIC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 17 THERMO FISCHER SCIENTIFIC: SWOT ANALYSIS
FIGURE 18 OXFORD NANOPORE: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 19 OXFORD NANOPORE: SWOT ANALYSIS
FIGURE 20 AGILENT TECHNOLOGIES, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 21 AGILENT TECHNOLOGIES, INC.: SWOT ANALYSIS
FIGURE 22 BGI.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 23 BGI.: SWOT ANALYSIS
FIGURE 24 PERKINELMER INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 25 PERKINELMER INC.: SWOT ANALYSIS
FIGURE 26 QIAGEN: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 27 QIAGEN: SWOT ANALYSIS
FIGURE 28 EUROFINS SCIENTIFIC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 29 EUROFINS SCIENTIFIC: SWOT ANALYSIS
FIGURE 30 HOFFMANN-LA ROCHE LTD: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 31 HOFFMANN-LA ROCHE LTD: SWOT ANALYSIS
FIGURE 32 TAKARA BIO INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 33 TAKARA BIO INC: SWOT ANALYSIS
FIGURE 34 TECAN GENOMICS, INC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 35 TECAN GENOMICS, INC: SWOT ANALYSIS

お買い物ガイド

よくある質問

この商品のレポートナンバー

0000038512

国内・海外の市場調査レポート販売

世界中の市場調査レポートを販売！当社に無いレポートもお探しします。